Achilles Investment Company Limited
17 September 2026
Achilles Investment Company Limited
Transaction in Own Shares
Further to the confirmation of its intention to implement a share buyback programme, as set out in its announcement on 9 September 2026, Achilles Investment Company Limited (the "Company") announces that on 16 September 2026 it purchased a total of 50,000 of its ordinary shares of no par value each ("Ordinary Shares") at a price of 103 pence per Ordinary Share through Singer Capital Markets. The Ordinary Shares purchased will be held in treasury.
Total voting rights
Following this purchase, the Company's total issued share capital consists of 54,000,000 Ordinary Shares of which 70,000 Ordinary Shares are held in treasury, therefore, the total number of Ordinary Shares carrying voting rights is 53,930,000. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information, please contact:
|
Achilles Investment Company Limited Charlotte Denton, Chair
|
Tel: +44 (0) 1481 743030 |
|
Harwood Capital Management (Gibraltar) Limited (Investment Manager) Robert Naylor
|
Tel: +44 (0) 20 7640 3200 |
|
Singer Capital Markets (Financial Adviser) James Moat / James Fischer - Corporate Finance Alan Geeves / Sam Greatrex - Sales
|
Tel: +44 (0) 20 7496 3000 |
|
NSM Funds Limited (Secretary)
|
Tel: +44 (0) 1481 743 030 achilles@nsm.group |
END OF ANNOUNCEMENT
LEI: 213800IVO9DDEIJD7724
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.